scholarly journals Human Peptidoglycan Recognition Protein 1 in Innate Immunity – A Review

Author(s):  
Jie Yang
1998 ◽  
Vol 95 (17) ◽  
pp. 10078-10082 ◽  
Author(s):  
D. Kang ◽  
G. Liu ◽  
A. Lundstrom ◽  
E. Gelius ◽  
H. Steiner

Blood ◽  
2005 ◽  
Vol 106 (7) ◽  
pp. 2551-2558 ◽  
Author(s):  
Ju Hyun Cho ◽  
Iain P. Fraser ◽  
Koichi Fukase ◽  
Shoichi Kusumoto ◽  
Yukari Fujimoto ◽  
...  

AbstractInnate immune responses to bacteria require cooperative interactions between host recognition molecules and phagocytes. The peptidoglycan recognition proteins (PGRPs) are a large group of proteins found in insects and mammals that bind to bacterial peptidoglycan (PGN). PGRP-S is located with other antimicrobial proteins, such as lysozyme, in the granules of human neutrophils. Whereas both PGRP-S and lysozyme recognize PGN, the exact binding specificity of human PGRP-S, its functional activity, and its potential synergy with other neutrophil-derived bactericidal proteins such as lysozyme have not been determined. Here we show that human PGRP-S binds to and inhibits the growth of Staphylococcus aureus (containing lysine-type PGN) and Escherichia coli (containing mesodiaminopimelic acid-type PGN). The binding affinity and thus antimicrobial activity of PGRP-S is determined by the third amino acid in the PGN stem peptide. Furthermore, the antimicrobial effect of PGRP-S against E coli is synergistic with lysozyme, and lysozyme and PGRP-S colocalize in neutrophil extracellular traps (NETs), suggesting that these granule-derived proteins act together to kill bacteria trapped in the NETs. Taken together, these results indicate that human PGRP-S plays a role in innate immunity in the context of neutrophils by contributing to the killing of intracellular and extracellular bacteria. (Blood. 2005;106:2551-2558)


2010 ◽  
Vol 79 (2) ◽  
pp. 858-866 ◽  
Author(s):  
Arihiro Osanai ◽  
Hiroshi Sashinami ◽  
Krisana Asano ◽  
Sheng-Jun Li ◽  
Dong-Liang Hu ◽  
...  

ABSTRACTThe role of mouse peptidoglycan recognition protein PGLYRP-1 in innate immunity againstListeria monocytogenesinfection was studied. The recombinant mouse PGLYRP-1 and a polyclonal antibody specific to PGLYRP-1 were prepared. The mouse PGLYRP-1 showed antibacterial activities againstL. monocytogenesand other Gram-positive bacteria. PGLYRP-1 mRNA expression was induced in the spleens and livers of mice infected withL. monocytogenes. The viable bacterial number increased, and the production of cytokines such as gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) was reduced in mice when mice had been injected with anti-PGLYRP-1 antibody before infection. The levels of IFN-γ and TNF-α titers in the organs were higher and the viable bacterial number was reduced in mice injected with recombinant mouse PGLYRP-1 (rmPGLYRP-1) before infection. PGLYRP-1 could directly induce these cytokines in spleen cell cultures. The elimination of intracellular bacteria was upregulated in NMuLi hepatocyte cells overexpressing PGLYRP-1. The enhancement of the elimination ofL. monocytogenesfrom the organs was observed in IFN-γ−/−mice by rmPGLYRP-1 administration but not in TNF-α−/−mice. These results suggest that PGLYRP-1 plays a role in innate immunity againstL. monocytogenesinfection by inducing TNF-α.


Sign in / Sign up

Export Citation Format

Share Document